CureVac NV (Germany) Market Value
| 5CV Stock | EUR 2.76 0.07 2.60% |
| Symbol | CureVac |
CureVac NV 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CureVac NV's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CureVac NV.
| 09/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in CureVac NV on September 30, 2024 and sell it all today you would earn a total of 0.00 from holding CureVac NV or generate 0.0% return on investment in CureVac NV over 60 days. CureVac NV is related to or competes with BioNTech, Moderna, Nel ASA, Ballard Power, and ITM Power. CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based o... More
CureVac NV Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CureVac NV's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CureVac NV upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 15.82 | |||
| Value At Risk | (4.97) | |||
| Potential Upside | 6.32 |
CureVac NV Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CureVac NV's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CureVac NV's standard deviation. In reality, there are many statistical measures that can use CureVac NV historical prices to predict the future CureVac NV's volatility.| Risk Adjusted Performance | 0.0022 | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (0.67) |
CureVac NV Backtested Returns
At this point, CureVac NV is risky. CureVac NV secures Sharpe Ratio (or Efficiency) of 0.0037, which signifies that the company had a 0.0037% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for CureVac NV, which you can use to evaluate the volatility of the firm. Please confirm CureVac NV's Risk Adjusted Performance of 0.0022, mean deviation of 2.54, and Standard Deviation of 3.38 to double-check if the risk estimate we provide is consistent with the expected return of 0.0126%. The firm shows a Beta (market volatility) of 0.0514, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CureVac NV's returns are expected to increase less than the market. However, during the bear market, the loss of holding CureVac NV is expected to be smaller as well. CureVac NV right now shows a risk of 3.4%. Please confirm CureVac NV treynor ratio, value at risk, and the relationship between the total risk alpha and maximum drawdown , to decide if CureVac NV will be following its price patterns.
Auto-correlation | 0.43 |
Average predictability
CureVac NV has average predictability. Overlapping area represents the amount of predictability between CureVac NV time series from 30th of September 2024 to 30th of October 2024 and 30th of October 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CureVac NV price movement. The serial correlation of 0.43 indicates that just about 43.0% of current CureVac NV price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.43 | |
| Spearman Rank Test | -0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
CureVac NV lagged returns against current returns
Autocorrelation, which is CureVac NV stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CureVac NV's stock expected returns. We can calculate the autocorrelation of CureVac NV returns to help us make a trade decision. For example, suppose you find that CureVac NV has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
CureVac NV regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CureVac NV stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CureVac NV stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CureVac NV stock over time.
Current vs Lagged Prices |
| Timeline |
CureVac NV Lagged Returns
When evaluating CureVac NV's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CureVac NV stock have on its future price. CureVac NV autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CureVac NV autocorrelation shows the relationship between CureVac NV stock current value and its past values and can show if there is a momentum factor associated with investing in CureVac NV.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in CureVac Stock
When determining whether CureVac NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CureVac NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Curevac Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Curevac Nv Stock:Check out CureVac NV Correlation, CureVac NV Volatility and CureVac NV Alpha and Beta module to complement your research on CureVac NV. For more detail on how to invest in CureVac Stock please use our How to Invest in CureVac NV guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
CureVac NV technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.